Eckert & Ziegler acquires Vitalea Science Inc. as Part of Strategic Move into Innovative Pharmaceutical Services

Berlin (ots) - Eckert & Ziegler Strahlen- und Medizintechnik AG,
through its Californian subsidiary Eckert & Ziegler Isotope Products,
Inc. (EZIP), has entered into a definite agreement with Vitalea
Science, Inc. for the purchase of all of its stock and assets.
Vitalea Science is a pioneering Bioanalytical Contract Research
Organization that provides services to researchers and clinicians in
drug development supported by validated Accelerator Mass Spectrometry
(AMS) technologies. This method is used in pre-clinic and clinic
studies for exploring the behavior of drug candidates in the
organism. Due to the AMS device's ultra-sensitivity it is able to
detect C14 tagged molecules in microdose levels. Vitalea also
provides AMS services for the characterization and identification of
non-medical carbon based compounds.

"Eckert & Ziegler Isotope Products is very excited to be adding
the capabilities and services of Vitalea Science to Eckert &
Ziegler's portfolio of offerings. Vitalea is a unique company with a
very unique capability built around the BioMICADAS(TM) device, which
is the state-of-the-art in AMS technology. We believe that this
capability will both allow Eckert & Ziegler to add value to our
existing customer base and expand our area of expertise in new
markets", said Frank Yeager, President & CEO of Eckert & Ziegler
Isotope Products.

"Bob Bethem, President & CEO at Vitalea Science, stated that "The
acquisition of Vitalea Science by Eckert & Ziegler helps to provide
the commercial strength of EZAG to the technical prowess of Vitalea.
We believe that this combination will help Vitalea to rapidly improve
its product offering and efficiency while adding new capabilities and
expertise at the same time. We look forward to being able to continue
expanding our business and helping our customers by providing world
class services and customer support."

Vitalea's scientists include the original developers of AMS
technology for applied bioscience at its location in Davis,
California near the University of California Davis campus, a leading
center for research into AMS, PET tracers and other early phase
medical studies.

Eckert & Ziegler Isotope Products has been producing
instrumentation and calibration standards for over forty five (45)
years. Today it is the world's leading manufacturer for nuclear
imaging reference and calibration standards and a leading producer of
radioactive components for industrial, scientific and medical
applications.

Its holding, the German based Eckert & Ziegler AG, is a global
isotope technology company that processes radioisotopes as well as
develops, manufactures and sells isotope technology components,
medical technology equipment and related products. The group employs
nearly 600 people worldwide. Throughout all of its subsidiaries it
generates yearly consolidated revenues in excess of $ 146 MM (116
Mio. EUR). Eckert & Ziegler AG is listed in the Prime Standard of the
German Stock Exchange in Frankfurt am Main (ISIN DE0005659700).

For further information, please contact:

Eckert & Ziegler AG
Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138
karolin.riehle@ezag.de, www.ezag.com

Eckert & Ziegler Vitalea Science
2121 Second St. Unit B101
Davis, CA 95618
T: +1.530.341.0200
F: +1.530.341.0299
www.vitaleascience.com

Media contact:
Ann Hoffman
T: +1.530.341.0200
E: ahoffman@vitaleascience.com (ann.hoffman@ezag.com)

Eckert & Ziegler Isotope Products Inc.:
24937 Avenue Tibbitts
Valencia, California 91355
T: 661.309.1010
F. 661.257.8308
www.ezag.com

Media contact:
JohnPaul Pascarelli
T: 661.309.1074
E: jpp@ezag.com